To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
Condition:   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Biological: CT-P17;   Biological: EU-approved Humira Sponsor:   Celltrion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis
Condition:   Psoriasis Vulgaris Interventions:   Drug: AKVANO-Calcipotriol formulation 1;   Drug: AKVANO-Calcipotriol formulation 2;   Drug: AKVANO vehicle formulation 1;   Drug: AKVANO vehicle formulation 2;   Drug: Daivonex solution;   Drug: Daivonex cream Sponsors:   Lipidor AB;   Bioskin GmbH Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 5, 2022 Category: Research Source Type: clinical trials

Value in Psoriasis
Condition:   Psoriasis Intervention:   Other: Patients receiving PsoPlus care Sponsors:   University Hospital, Ghent;   Novartis;   Janssen, LP;   Vlerick Business School;   Scientific Research Foundation-Flanders Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials